Study details
Enrolling now
Pilot Trial to Understand Allergic Airway Inflammation
Benjamin Medoff
NCT IDNCT00595491ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
313
Study length
about 21 years
Ages
18–50
Locations
1 site in MA
What this study is about
This trial is testing a new way to understand how allergic reactions cause inflammation in the airways. It involves examining cells and receptors involved in this process, which could lead to better treatments for asthma.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Respiratory